Home › Funds › GW&K Investment Management, LLC › ABBV

GW&K Investment Management, LLC position in ABBV

ABBVIE INC · Health Care

GW&K Investment Management, LLC reported holding 271,024 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$70.9M, representing 0.60% of its reported portfolio and ranking #42 among its reported holdings. GW&K Investment Management, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)271.02K sh
Reported value held$70.90M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GW&K Investment Management, LLC's ABBV position evolved

GW&K Investment Management, LLC first disclosed a stake in ABBV in Q3 2023 at 345,740 shares (US$51.5M). The position peaked in Q3 2025 at 375,778 shares, worth US$87.0M. Across 13 filings, GW&K Investment Management, LLC increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 271,024 shares valued at US$70.9M — a reduction of -4,715 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2025 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 345.74K $51.54M New
Q4 2023 336.54K $52.15M Reduce
Q1 2024 332.86K $60.61M Reduce
Q2 2024 325.85K $55.89M Reduce
Q3 2024 320.78K $63.35M Reduce
Q4 2024 313.49K $55.71M Reduce
Q1 2025 396.73K $83.12M Add
Q2 2025 381.99K $70.90M Reduce
Q3 2025 375.78K $87.01M Reduce
Q4 2025 374.93K $85.67M Hold
Q1 2026 309.42K $67.30M Reduce
Q2 2026 275.74K $69.39M Reduce
Q3 2026 271.02K $70.90M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has GW&K Investment Management, LLC held ABBV?

GW&K Investment Management, LLC has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GW&K Investment Management, LLC's current position in ABBV?

As of Q3 2026, GW&K Investment Management, LLC holds 271.02K shares of ABBV (ABBVIE INC), valued at $70.90M, representing 0.60% of its reported portfolio and ranking #42.

Has GW&K Investment Management, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC reduced its position in ABBV. The position peaked in Q3 2025 at 375.78K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.